The care and earlier diagnosis of lung cancer patients is at a pivotal stage in the UK and the optimal pathway of care is becoming ever more complex and specialised. The pandemic knocked us…
Blogs
The Covid-19 pandemic, together with the current cost of living crisis, have shone a…
Lung cancer is a rapidly fatal disease and therefore early diagnosis is vital.
Earlier this year, like many other organisations in the lung cancer space, the…
The National Lung Cancer Audit (NLCA) published its 2022 annual report last week (14th…
Prior to the pandemic, real progress was being made in raising five-year lung cancer survival rates in the UK. However, COVID-19 has had a devastating impact on early diagnosis of lung cancer and…
When the COVID-19 pandemic hit, healthcare professionals across the NHS went to extraordinary lengths to keep patients as safe as possible. This was especially important in lung cancer, where…
Whilst the overall outcomes for lung cancer across the world remain poor compared to many other cancers, and survival of patients in the UK has consistently been shown to be worse than in many…
Over the last six months the world has changed beyond recognition as people and organisations have adapted to lockdowns, social distancing and working remotely. The NHS has been remarkably adept…
We are delighted and proud to announce that Professor Mick Peake has been awarded an OBE for his services to medicine in the Queen’s Birthday Honours list.
Without a doubt, lung cancer…